Oxycodone and Aspirin (Mayne Pharma Inc.)


Welcome to the PulseAid listing for the Oxycodone and Aspirin drug offered from Mayne Pharma Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mayne Pharma Inc.
NON-PROPRIETARY NAME: Oxycodone Hydrochloride and Aspirin
SUBSTANCE NAME: OXYCODONE HYDROCHLORIDE; ASPIRIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-05-02
END MARKETING DATE: 0000-00-00


Oxycodone and Aspirin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOxycodone and Aspirin from Mayne Pharma Inc.
LABELER NAME: Mayne Pharma Inc.
DEA SCHEDULE: CII
ACTIVE STRENGTH: 4.8355; 325(mg/1; mg/1)
START MARKETING DATE: 2011-05-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68308-845_25317902-96bb-4fa4-ac0c-35e362b41935
PRODUCT NDC: 68308-845
APPLICATION NUMBER: ANDA091670

Other OXYCODONE HYDROCHLORIDE; ASPIRIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Oxycodone and Aspirin
Mayne Pharma Inc.Oxycodone and Aspirin
STAT RX USA LLCENDODAN